BASEL, SWITZERLAND     5 November 2019

Prior to 17th European AIDS Conference


THE EUROPEAN HIV CLINICAL FORUM: OPTIMIZING TREATMENT IS COMING TO BASEL ON 5 NOVEMBER 2019! The 5th edition will be held just prior to 17th European AIDS Conference.


The European HIV Clinical Forum provides an independent scientific program involving the world’s leading experts and is especially designed for the European HIV healthcare professionals with the focus on optimizing treatment for their patients. The meeting is scheduled prior to the 17th European AIDS Conference (EACS) in Basel, Switzerland, which will allow healthcare professionals to combine both meetings in one trip thus limiting travel time and the number of days away from the clinic. 

This state-of-the-art program provides challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction and the sharing of knowledge within the HIV-treating community in Europe. Additionally, the program includes abstract presentations and clinical cases, in which the medical community shares their clinical experience by presenting and discussing real-life cases.


Access the meeting proceedings of the 




Last year's edition of the European HIV Clinical Forum was organized on 27 October 2018, just prior to the HIV Glasgow conference 2018. The forum attracted nearly 60 participants, from 14 European countries. The focus of last year's meeting was on important clinical developments and updates on ongoing and new trials in the field of integrase inhibitors. The program featured several invited lectures and clinical cases discussions. The day ended with a social get together over drinks, providing a unique opportunity to meet colleagues from different countries.

Feedback from the participants showed that the workshop was very well received. 97% of the respondents indicated that the lectures have increased their knowledge, 94% agreed that the program was beneficial for the clinical management of their patients, and 88% reported that they intend to incorporate the new information from the workshop into the care of their patients.



The HIV CLINICAL FORUM is developed  as part of a series of interactive programs that provide independent  medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts / research programs.


Furthermore, the HIV CLINICAL FORUM encourages skills building for optimal interpretation of research results, developing  collaborations and initiating research projects.


Charles Boucher

Erasmus Medical Center,

the Netherlands

Jonathan Schapiro

Sheba Medical Center,



Register for the

European HIV Clinical Forum

Basel | 5 November 2019

Marcel Stöckle

University Hospital Basel,




09:00h     Welcome, Introduction and Goals  

                Jonathan Schapiro, MD - Sheba Medical Center, Israel

09:10h     Needs Assessment

Session 1 - Position of INSTIs in clinical management of PLWH

Chairs: Jonathan Schapiro & Marcel Stöckle

09.15h     First line regimens in different European countries 2019 – an overview     

                Milosz Parczewski, MD, PhD - Pomeranian Medical University, Szczecin, Poland

09.40h     Second generation INSTI regimens for drug naive patients: State of the Art 

                Daniel Kuritzkes, MD - Brigham and Women's Hospital / Harvard Medical School, Cambridge, USA

10.05h     Abstract - Longitudinal trends in self-reported side effects and prescribed 3rd agent in ART 

                Gaetano Marrone, Prof. - Department Of Infectious Disease, Karolinska Hospital, Stockholm 

10.15h     Discussion

10:30h     Coffee Break

Session 2 - Treatment and Prevention: State of the Art

Chairs: Anne-Geneviève Marcelin & Saye Khoo

10.55h     When to start antiretroviral therapy after diagnosis – trade-offs and considerations                          

                Anton Pozniak, MD, FRCP - Chelsea and Westminster Hospital, London, UK

Round table on PrEP

11.20h     Update on PrEP use in Europe                                                                                                                      

                 Ann Sullivan, MBBS, DIPGUM, DFFP, MD, FRCP - Chelsea and Westminster Hospital,

                London, UK

11.40h     Challenges of long-term PrEP                                                                                                                          

                Pep Coll, MD - AIDS Research Institute-IrsiCaixa, Badalona, Spain

12.00h     Oral versus injectable PrEP                                                                                                                         

                Saye Khoo, MD, PhD - University of Liverpool, Liverpool, UK

12.20h     Discussion

12.35h     Evaluation Form - Morning Program

12:45h     Lunch

Session 3 - Novel treatment options

Chairs: Anton Pozniak & Laura Waters

13.45h     New treatments and treatment paradigms                                                            

                Sharon Walmsley, CM, MD, FRCPC - University Health Network, Toronto, Canada

14.10h     Long acting parenteral antiretroviral regimens - where might they fit?                                                     

                Saye Khoo, MD, PhD - University of Liverpool, Liverpool, UK

14.35h     Single tablet regimens versus multiple pills – is there a meaningful difference?                      

                Bonaventura Clotet, MD, PhD - Fundació Irsicaixa, Badalona, Spain

15.00h     Abstract - HIV and Ageing - Primary and secondary prevention of coronary artery disease among People living with HIV 

                Gaetano Marrone, Prof. - Karolinska Hospital, Stockholm 

15.10h     Discussion

15:20h     Coffee Break

Session 4 - Round table on long-term ramifications of expanded global first line second-generation INSTI use

Moderators: Dan Kuritzkes & Bonaventura Clotet

Round table on long-term ramifications of expanded global first line second-generation INSTI use

15.50h     Impact on transmitted and acquired drug resistance                                                                         

                Anne-Geneviève Marcelin, PharmD, PhD - Hôpital Pitié-Salpétrière, France


16.05h     Impact on women’s health & weight gain                                                                                                  

                Laura Waters, MD - Central & North West London NHS Trust, London, UK

16.20h     Impact on children and adolescence                                                                                                

                Natella Rakhmanina, MD, PhD - The George Washington University, Children’s

                National Health System, Washington, US

16.35h     Discussion

17.05h     Evaluation Form - Afternoon Program

17:15h     Closing remarks



Registration is free of charge for all healthcare practitioners*. A registration fee applies to other individuals.

*Healthcare practitioners are defined as professionals that provide any type of health care service to patients living with HIV. If you are not sure, please do not hesitate to contact us at



Virology Education (VE), with generous support by Gilead is offering Scholarships for the European HIV Clinical Forum to HIV healthcare professionals from Europe. (Please note: any applications from outside Europe will automatically be declined).

What the Scholarship covers:
  1. Free registration for the European HIV Clinical Forum

  2. Support for air travel of up to EUR 600

  3. Hotel accommodation for 2 nights on 4-5 November 2019

a)    All arrangements will be made by Virology Education
b)    Applicants must attend the entire Conference.
c)    Applicants will be responsible for all other costs associated with Conference attendance. 
d)    Please see the Conference website for further details about the Conference. 

What is expected from you:
  1. Recipient will be onsite at the Conference, attend all sessions and participate actively for the duration of the Conference. Recipient must sign in to each session as requested by VE. 

  2. Recipient will provide a post-meeting feedback and summary about his/her Conference experience within 1 month after the end of the Conference. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the conference, Scholarship procedure and how they will implement the knowledge acquired at the meeting in their daily practice. The questionnaire will be send to each recipient by email within one week after the conclusion of the conference.

  1. The applicant must be a Healthcare Professional.

  2. The applicant must be from the European Union.

  3. The applicant must be willing to share his/her experience at the Conference within his network.

  4. The applicant must be eligible to obtain a visa for travel.

  5. The applicant must declare that she/he is able and willing to fund all other costs beyond the grant that are involved in attending the Conference, e.g. all other hotel, travel and subsistence expenses NOT covered by the Scholarship.

  6. The applicant must declare to take out her/his own insurance policies (for travel, liability, illness and/or other necessary insurances in relation to her/his participation to the Conference).


Application procedure:
  1. Your application will include the following:

  • Your contact details (e.g. name and email address)

  • CV

  • Motivation letter consisting of a written statement of up to 200 words, on

    • how attending the Conference will benefit you in a professional capacity

    • how you intend to apply the benefits that you have outlined in a practical way after the Conference

  • Recommendation letter(s) (optional)

  • Abstract(s) (optional)

  • A declaration that you agree with the terms & conditions for application

  1. Your application must be received by Sunday 6 October

  2. All applications will be acknowledged upon receipt.

  3. All applications will be reviewed by an independent Scholarship Review Committee based on the following Grant Selection Criteria:

    • Professional background

    • Strategy of knowledge dissemination

    • Recommendation by the Scientific and Organizing Committee of the meeting

    • Quality of the Abstract (if accepted)

    • Young/ Early Career Investigator

  4. All applicants will receive notification of the application status no later than 14 October 2019.


Please submit your application through the Scholarship Application Portal on the Conference website.  

We humbly request your support in encouraging healthcare professionals to apply by forwarding this information to your colleagues.


Are you doing research on one of the topics below and have data that you would like to share and/or discuss with your colleagues? Then we encourage you to submit your abstract!


Please note that those with accepted abstract will be offered a Scholarship (guaranteed).

Abstract topics:
•    Basic Virology
•    Resistance
•    Pharmacology and Drug interactions
•    Toxicity
•    Reduced Drug Regimens
•    Clinical Trials
•    Informative case reports

General guidelines
Abstracts should contain the following four components (please bold the four section headings noted below within the text of your abstract submission):


Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included. We advise you to keep a word count for the abstract body to a maximum of 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially.

Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.


Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting authors before 11 October 2019. It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status.

Please notify the Conference Secretariat if you have not received notification by 14 October 2019.

If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled.

Abstract Submitter’s Registration Guidelines will be sent together with the notification. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Conference Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal "Reviews in Antiviral Therapy & Infectious Diseases". Please note that the Conference Secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.


Terms and Conditions:
• Please note that the Conference Secretariat cannot be held responsible for any typing or language errors in the submitted abstracts.
• The Organizing Committee may decide to allocate your abstract to a different topic than the topic for which it was submitted.
• At least one listed author of each accepted abstract must register (paying the relevant registration fee) and attend the Workshop to present the abstract.
• Submitting authors will be notified of the Organizing Committee decision. The Organizing Committee decision is final and no correspondence will be entered into.
• Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. Abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases and will be made freely available online at
• All communications regarding this abstract will be directed to you as abstract submitter. It is your responsibility to inform your co-authors of the abstract acceptance status.



The European HIV Clinical Forum 2019 is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

This program has been made possible by an unrestricted educational grant from Gilead Sciences.




Practical Information

We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay in Basel.


Accommodation for grantees will be arranged at Ibis Styles Basel City, located 2 minutes away from the meeting venue.

Ibis Styles Basel City

Grosspeterstrasse 44

4052 Basel


T: +41 (0) 61 554 04 44





Make sure to pick up your badge at the registration desk. All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting and venue.


Certificate of Attendance

A certificate of attendance will be sent by e-mail after the workshop.


Conference materials

Conference materials can be obtained upon registration at the registration desk at the conference venue starting 8:00 AM

on Tuesday, 5 November.


Conference language

The official conference language is English.



This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.


Liability and insurance

By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.


Meeting venue

The meeting will be held at Novotel Basel City, a hotel located in the center of Basel.

Novotel Basel City

Grosspeterstrasse 12

4052 Basel


T: +41 (0) 61 306 68 08




Internet access

Free Wi-Fi will be available in the meeting room. Access codes will be made available on the first day of the meeting.

Payment and procedure of on-line registration

Registration is free of charge for all healthcare practitioners. Your registration will be confirmed as soon as possible. If you do not receive a confirmation within three days after your registration, please contact the organizing secretariat email:


Photographs, audio and video recording

Photographs as well as audio and video recordings are not permitted at the official meeting sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations, will be posted on the workshop website (under Workshop Materials) as soon as possible after the workshop is finished, provided the speaker has given permission to do so.




For any inquiries or questions, please contact Virology Education at or call +31 (0)30 230 7140. You can also contact us by filling out the contact form.

Jesper Niesen

Project Manager

Dagmar Jonasdottir

Junior Logistics Manager

Contact form